Cover 2 Resources
Cover 2 Resources
Ep 268 - Rudy Giuliani & The Lost Opportunity to Make Them Pay
Ep 268 - Rudy Giuliani & The Lost Opportunity to Make Them Pay
Ep 268 - Rudy Giuliani & The Lost Opportunity to Make Them Pay
Monday 6th January 2020
Paul Pelletier, Dave Aronberg, and Chris McGreal discuss the controversial Purdue Pharma settlement and its impact on the opioid crisis in this Cover2 Resources episode.
30 minutes
Informative
Eye-opening
Thought-provoking
Raw
Engaging
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Purdue Pharma Settlement: Uncovering the Missed Chance for Justice
The ease with which Purdue Pharma got away with accountability had opened the door to them, just carrying on as before, and I think that's perhaps the other big takeaway from this.
In 2006, Purdue Pharma found itself in hot water for misleading the public about the addictiveness of OxyContin. Many believed that severe penalties were in order, and the Department of Justice (DOJ) seemed to agree. However, Giuliani Partners LLC managed to negotiate a settlement that let Purdue and its top executives off the hook. This decision sent a troubling message: the deaths of thousands of Americans were just business as usual for Big Pharma.
Fast forward to August 2019, when The Weekly, a New York Times documentary series, aired an episode featuring a leaked prosecution memo. This memo revealed that government investigators had strong evidence that Purdue Pharma knew OxyContin was fueling addiction. Why did it take over a decade for this memo to surface? Could its earlier exposure have lessened the opioid crisis?
In this eye-opening episode, Paul Pelletier, former Deputy Chief of the DOJ’s Fraud Section, joins returning guests Dave Aronberg, State Attorney of Palm Beach County, and Chris McGreal, an award-winning author. Together, they explore the decisions and conflicts of interest that led to the controversial settlement. They also discuss Rudy Giuliani's role and how Purdue's dealings with the DEA and DOJ might have influenced the outcome.
This episode dives deep into the accountability of Big Pharma and the ongoing opioid epidemic, offering valuable insights into one of America's most pressing health crises.